Acromegaly Drug Signifor by Novartis Receives EU Approval Acromegaly complications worsen over time leading to death. The approval of the Novartis drug Signifor should help lessen mortality rates in the EU, with the rest of the world following suit eventually. by Dianne Depra
Healthy Living/Wellness Novartis reports efficacy of Signifor LAR for acromegaly after Phase III trial by Rhodi Lee